These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1799624)

  • 21. [Cerebral toxoplasmosis in patients with human immunodeficiency virus (HIV) infection. Clinico-radiological and therapeutic aspects in 63 patients].
    Ferrer S; Fuentes I; Domingo P; Muñoz C; Iranzo A; Barrio JL; Fuster M; Ris J; Sambeat MA; Cadafalch J; Nolla J
    An Med Interna; 1996 Jan; 13(1):4-8. PubMed ID: 8679824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience.
    Roemer E; Blau IW; Basara N; Kiehl MG; Bischoff M; Günzelmann S; Kirsten D; Sanchez H; Wocker EL; Fauser AA
    Clin Infect Dis; 2001 Jan; 32(1):E1-8. PubMed ID: 11118397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine.
    Bouboulis DA; Rubinstein A; Shliozberg J; Madden J; Frieri M
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):491-4. PubMed ID: 7788516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Toxoplasmosis: new aspects, diagnosis and treatment].
    Oksenhendler E; Matheron S
    Rev Prat; 1992 Jan; 42(2):155-9. PubMed ID: 1565998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A possible novel mechanism of opportunistic infection in systemic lupus erythematosus, based on a case of toxoplasmic encephalopathy.
    Seta N; Shimizu T; Nawata M; Wada R; Mori K; Sekigawa I; Iida N; Maeda M; Hashimoto H
    Rheumatology (Oxford); 2002 Sep; 41(9):1072-3. PubMed ID: 12209046
    [No Abstract]   [Full Text] [Related]  

  • 26. [Recurrence of cerebral toxoplasmosis in 15 AIDS patients].
    Walckenaer G; Leport C; Longuet P; Perronne C; Lacassin F; Vildé JL
    Ann Med Interne (Paris); 1994; 145(3):181-4. PubMed ID: 8092633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HIV infection and Lyell syndrome: a wake-up call concerning anti-inflammatory agents].
    de Luis DA; Fortun J; Pintado V; Aller de la Fuente R
    Enferm Infecc Microbiol Clin; 1997 Apr; 15(4):231-2. PubMed ID: 9312293
    [No Abstract]   [Full Text] [Related]  

  • 28. [Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].
    Niyongabo T; Leport C; Vildé JL
    Presse Med; 1991 Oct; 20(34):1677-81. PubMed ID: 1836573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebral toxoplasmosis treated with clindamycin alone in an HIV-positive patient allergic to sulfonamides.
    Yapar N; Erdenizmenli M; Oğuz VA; Cakir N; Yüce A
    Int J Infect Dis; 2005 Jan; 9(1):64-6. PubMed ID: 15603998
    [No Abstract]   [Full Text] [Related]  

  • 30. Levels of pyrimethamine in serum and penetration into brain tissue in humans.
    Leport C; Meulemans A; Robine D; Dameron G; Vildé JL
    AIDS; 1992 Sep; 6(9):1040-1. PubMed ID: 1388895
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS].
    Langmann P; Klinker H; Richter E
    Dtsch Med Wochenschr; 1995 May; 120(21):780-1. PubMed ID: 7781508
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of clindamycin in the treatment of acute toxoplasmosis of the central nervous system.
    Ruf B; Pohle HD
    Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):183-6. PubMed ID: 2060525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Issues in toxoplasmosis.
    McCabe R; Chirurgi V
    Infect Dis Clin North Am; 1993 Sep; 7(3):587-604. PubMed ID: 8254161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of clindamycin in the treatment of central nervous system toxoplasmosis.
    Rolston KV; Hoy J
    Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Seroprevalence of toxoplasmosis in 346 HIV infected patients in the east of France. Serological follow-up study in patients not infected with Toxoplasma gondii].
    Candolfi E; Partisani ML; De Mautort E; Bethencourt S; Frantz M; Kien T; Lang JM
    Presse Med; 1992 Feb; 21(8):394-5. PubMed ID: 1533032
    [No Abstract]   [Full Text] [Related]  

  • 36. Toxoplasmosis in AIDS patients.
    Tuazon CU
    J Antimicrob Chemother; 1989 Jan; 23 Suppl A():77-82. PubMed ID: 2654118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clindamycin in the treatment of cerebral toxoplasmosis in a patient with AIDS].
    Santos Gil I; Noguerado Asensio A; del Arco Galán C; García Polo I
    Rev Clin Esp; 1989 Jun; 185(1):47. PubMed ID: 2772341
    [No Abstract]   [Full Text] [Related]  

  • 38. Sulfadiazine/N4-acetylsulfadiazine crystalluria in a patient with the acquired immune deficiency syndrome (AIDS).
    Potter JL; Kofron WG
    Clin Chim Acta; 1994 Oct; 230(2):221-4. PubMed ID: 7834873
    [No Abstract]   [Full Text] [Related]  

  • 39. Duodenal and hepatic toxoplasmosis in a patient with HIV infection: review of the literature.
    Bonacini M; Kanel G; Alamy M
    Am J Gastroenterol; 1996 Sep; 91(9):1838-40. PubMed ID: 8792710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.
    Leport C; Bastuji-Garin S; Perronne C; Salmon D; Marche C; Briçaire F; Vilde JL
    J Infect Dis; 1989 Sep; 160(3):557-8. PubMed ID: 2760509
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.